NCT04593420View on ClinicalTrials.gov

Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.

CompletedOBSERVATIONAL
Enrollment

817

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

December 8, 2022

Study Completion Date

December 8, 2022

Conditions
Prostate Cancer
Trial Locations (1)

Unknown

Ipsen Central Contact, Paris

Sponsors

Lead Sponsor

Ipsen
All Listed Sponsors
lead

Ipsen

INDUSTRY